Wei Chen
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Hepatology top 1%
- Liver physiology and pathology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 12
- Kruppel-like factors research 11
- Epidemiology 76
- Liver Disease Diagnosis and Treatment 48
- Co-authors
- Bruce R. Blazar (3 shared papers)Xueqing Liang (2 shared papers)David H. Munn (2 shared papers)Chuan Qin (6 shared papers)Hong You (20 shared papers)Aiting Yang (15 shared papers)Jidong Jia (7 shared papers)Hui Han (15 shared papers)
- Journals
- Hepatology Communications (6 papers)PLoS ONE (6 papers)Hepatology (5 papers)Frontiers in Pharmacology (5 papers)Scientific Reports (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wei Chen
297 papers receiving 7.1k citations
Wei Chen's Hit Papers
Peers
Comparison fields: 5 of 187
- Biological Psychiatry 384
- Hepatology 613
- Cell Biology 978
- Cancer Research 872
- Molecular Biology 3.2k
Countries citing papers authored by Wei Chen
This map shows the geographic impact of Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Chen more than expected).
Fields of papers citing papers by Wei Chen
This network shows the impact of papers produced by Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Chen. The network helps show where Wei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 311 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 370 | |
| 2 | 2017 | 364 | |
| 3 | 2007 | 334 | |
| 4 | 2013 | 283 | |
| 5 | 2011 | 242 | |
| 6 | 2001 | 215 | |
| 7 | 2020 | 181 | |
| 8 | 2006 | 152 | |
| 9 | 2020 | 131 | |
| 10 | 2021 | 100 | |
| 11 | 1999 | 95 | |
| 12 | 2016 | 86 | |
| 13 | 2017 | 84 | |
| 14 | 2013 | 83 | |
| 15 | 2015 | 83 | |
| 16 | 2012 | 80 | |
| 17 | 2019 | 80 | |
| 18 | 1998 | 72 | |
| 19 | 2015 | 70 | |
| 20 | Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis Hit paper breakdown → | 2023 | 69 |
About Wei Chen
Wei Chen is a scholar working on Molecular Biology, Epidemiology, Surgery, Hepatology and Cardiology and Cardiovascular Medicine, having authored 311 papers that have together received 7.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (48 papers), Liver physiology and pathology (27 papers), MicroRNA in disease regulation (15 papers), Viral Infections and Immunology Research (14 papers), Liver Disease and Transplantation (13 papers), Cancer-related molecular mechanisms research (12 papers), Peroxisome Proliferator-Activated Receptors (12 papers) and Kruppel-like factors research (11 papers). The work is most often cited by research in Biological Psychiatry (384 citations), Hepatology (613 citations), Cell Biology (978 citations), Cancer Research (872 citations) and Molecular Biology (3.2k citations). Wei Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bruce R. Blazar, Xueqing Liang, David H. Munn, Chuan Qin, Hong You, Aiting Yang, Jidong Jia, Hui Han, Kemper Lewis and Zhuolun Song. Their work appears in journals such as Hepatology Communications, PLoS ONE, Hepatology, Frontiers in Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.